Indican is a compound found in urine that forms when gut bacteria break down the amino acid tryptophan. Your body makes small amounts all the time, and trace levels in urine are normal. When levels climb well above that baseline, though, it typically signals that something in the digestive tract has gone off-track, whether that’s sluggish digestion, bacterial overgrowth, or impaired protein absorption. The story of indican also extends beyond the gut, intersecting with kidney disease, cardiovascular health, and even brain function in ways that make it more than just a niche lab marker.
How Indican Gets Made
The production line starts with tryptophan, one of the essential amino acids you get from food. Normally, most dietary tryptophan gets absorbed in the small intestine before bacteria have much chance to act on it. But when tryptophan lingers too long or reaches the large intestine in larger-than-usual quantities, resident gut bacteria convert it into indole using an enzyme called tryptophanase. Indole is one of several microbial tryptophan metabolites; others include compounds like indole-3-acetic acid and indole-3-propionic acid, all produced through what researchers call the indole pathway of tryptophan metabolism.1International Immunology. The tryptophan metabolic pathway of the microbiome and host cells in health and disease
Once formed, indole gets absorbed through the intestinal wall and travels to the liver. There, a liver enzyme called CYP2E1 oxidizes it into indoxyl.2PubMed Central. Hepatic microsomal metabolism of indole to indoxyl, a precursor of indoxyl sulfate Indoxyl is then conjugated with sulfate, forming indoxyl sulfate, and the body excretes it in urine.3PubMed. Oxidation of indole by cytochrome P450 enzymes This urinary indoxyl sulfate is what clinicians have historically called “urinary indican.” So when a test reports your indican level, it’s really measuring how much of this sulfate-conjugated indole byproduct is being flushed out by your kidneys.
There’s actually a naming quirk worth knowing. The word “indican” refers to two different chemicals depending on the context. In botany, indican is a plant compound, a glucoside of indoxyl found in the indigo plant Indigofera tinctoria, which is the basis of natural indigo dye. In human physiology, indican refers to the sulfate conjugate of indoxyl found in urine. They share a name because both ultimately yield indigo blue when chemically oxidized, but they are structurally different molecules.
What Elevated Indican Tells You
A high urinary indican level is generally a sign that excessive bacterial fermentation of tryptophan is happening somewhere in the gut. The question is why. Several digestive problems can create the conditions for this.
- Low stomach acid: Hypochlorhydria reduces the stomach’s ability to begin protein digestion, meaning larger protein fragments reach the lower gut where bacteria can ferment them.
- Pancreatic insufficiency: If the pancreas doesn’t produce enough digestive enzymes like trypsin and chymotrypsin, protein digestion slows and more undigested tryptophan becomes available to gut bacteria.4PubMed. What Is Indican and What Do High Levels Mean?
- Small intestinal bacterial overgrowth: When bacteria colonize the small intestine in abnormally high numbers, they intercept tryptophan before it can be absorbed, converting it to indole in a part of the gut where this process wouldn’t normally occur at scale.
- Intestinal obstruction or slow transit: Anything that slows the movement of food through the gut gives bacteria more time to break down tryptophan. Conditions that reduce peristalsis or physically block the bowel can push indican levels up sharply.
The common thread is that protein, specifically tryptophan, is spending too much time in contact with bacteria that can convert it to indole. Elevated indican doesn’t tell you which of these problems is the cause; it’s a flag that something upstream in digestion is off, and further investigation is needed to figure out what.
Testing for Indican
The oldest method for detecting indican in urine dates back well over a century. In 1898, a JAMA paper described how clinicians would break apart indoxyl sulfate using hydrochloric acid, oxidize the freed indoxyl into indigo blue, dissolve it in chloroform, and gauge how intense the blue color was.5JAMA. A Method for the Quantitative Estimation of Indican and Indirubin in the Urine That same paper noted these colorimetric tests were mostly qualitative and “of little or no value for clinical diagnosis” when it came to precise measurement. The Obermayer test, a related method that uses fuming hydrochloric acid and relies on aerial oxygen to produce the characteristic blue color, became more widely used in clinical practice over the following decades.
Modern labs that still offer indican testing have moved to more precise analytical tools. Liquid chromatography with tandem mass spectrometry can detect and measure a panel of urinary aromatic acids, including indican, with a simple sample preparation step and results in minutes.6PubMed. Analysis of urinary aromatic acids by liquid chromatography tandem mass spectrometry This is a substantial upgrade over the blue-dye-in-a-test-tube approach, both in accuracy and in the ability to measure multiple related metabolites at once.
That said, urinary indican testing occupies an unusual spot in modern medicine. It’s used more commonly in integrative and functional medicine practices than in mainstream clinical settings. Many conventional physicians have never ordered the test, and it doesn’t appear on standard metabolic panels. This doesn’t mean the test is useless, but it does mean the interpretation of results often happens outside the context of well-established clinical guidelines. If you get an indican result back, it’s worth discussing with someone who understands both the test’s strengths and its limitations.
The Indoxyl Sulfate Problem in Kidney Disease
While indican in urine is a relatively low-stakes marker in people with healthy kidneys, its precursor indoxyl sulfate becomes a serious concern when kidney function declines. In chronic kidney disease, the kidneys lose their ability to clear indoxyl sulfate efficiently, so it accumulates in the blood. And indoxyl sulfate isn’t just passively sitting there; it actively damages the kidneys further.
Research has shown that indoxyl sulfate is directly toxic to the tubular cells that form the kidney’s filtration system. It triggers both programmed and uncontrolled cell death in these cells, ramps up oxidative stress, and suppresses the kidney’s antioxidant defenses. The injured tubular cells then release signaling molecules that recruit inflammatory cells and promote the scarring process known as renal fibrosis.7PubMed Central. Indoxyl Sulfate, a Tubular Toxin, Contributes to the Development of Chronic Kidney Disease This creates a vicious cycle: kidney damage leads to higher indoxyl sulfate levels, which cause more kidney damage, which leads to even higher levels. Clinically, higher blood levels of indoxyl sulfate are independently linked to faster kidney function decline and higher overall mortality in people with kidney disease.
A systematic review examining the toxicity of both indoxyl sulfate and a related compound, p-cresyl sulfate, confirmed their roles in driving both kidney and vascular disease progression.8PubMed Central. The Uremic Toxicity of Indoxyl Sulfate and p-Cresyl Sulfate: A Systematic Review This is an important distinction: indoxyl sulfate isn’t merely a consequence of failing kidneys. The evidence increasingly points to it as an active contributor to the disease getting worse.9Russian Military Medical Academy Reports. Uremic toxin indoxyl sulfate and progression of chronic kidney disease
Cardiovascular Effects
The damage from elevated indoxyl sulfate doesn’t stay confined to the kidneys. People with chronic kidney disease have dramatically higher rates of cardiovascular disease than the general population, and indoxyl sulfate appears to be part of the reason. Research has demonstrated that indoxyl sulfate has adverse effects on the heart and accelerates vascular dysfunction, suggesting it contributes to the high prevalence of cardiovascular disease seen in kidney disease patients.10PubMed. Role of uremic toxin indoxyl sulfate in the progression of cardiovascular disease
In animal models, an oral carbon adsorbent called AST-120, which works by binding indoxyl sulfate precursors in the gut before they can be absorbed, has shown the ability to slow the progression of atherosclerosis (plaque buildup in arteries) in mice with chronic kidney failure. The treatment preserved the expression of a protective molecule called sFlt-1 in the kidneys and significantly reduced the area of atherosclerotic plaque in the aorta compared to untreated animals.11Scientific Reports. AST-120, an Oral Carbon Absorbent, Protects against the Progression of Atherosclerosis in a Mouse Chronic Renal Failure Model by Preserving sFlt-1 Expression Levels AST-120 is approved for clinical use in some countries for patients with kidney disease, though it hasn’t achieved widespread adoption everywhere. The underlying logic is simple: if you can reduce how much indole gets absorbed from the gut, you can lower indoxyl sulfate levels in the blood and potentially slow the downstream damage.
Can Probiotics Lower Indican?
Given that gut bacteria are the starting point of the whole indican production chain, reshaping the microbial community is a logical intervention target. And the evidence here is surprisingly encouraging. In a randomized, placebo-controlled trial of patients with mild kidney insufficiency, a specific probiotic protocol significantly reduced urinary indican levels. After treatment, average urinary indican in the probiotic group dropped to about 7 mg/l, while the placebo group remained at roughly 24 mg/l.12PubMed Central. An open-label, randomized, placebo-controlled study on the effectiveness of a novel probiotics administration protocol (ProbiotiCKD) in patients with mild renal insufficiency (stage 3a of CKD)
Earlier research had already laid the groundwork for this finding. Studies in both rats and humans showed that Lactobacillus species, when they colonize the gut at sufficiently high numbers, reduce urinary indican excretion. The effect tracked with how many lactobacilli were present in the stool: a meaningful reduction in indican only appeared when fecal lactobacillus counts exceeded a certain threshold. In humans, subjects with higher resident lactobacillus populations excreted less indican, and the relationship held up as a statistically significant negative correlation. The mechanism appears to involve a decrease in tryptophanase activity, the bacterial enzyme that converts tryptophan to indole in the first place.13PubMed. Effect of lactobacilli on urinary indican excretion in gnotobiotic rats and in man
This paints a coherent picture: if you can shift the gut microbiome toward species that don’t produce much indole and away from heavy tryptophanase producers, indican levels should drop. Probiotics are one tool for doing this, though the specific strains and doses matter. Dietary changes that improve protein digestion higher up in the gut (so less undigested tryptophan reaches the colon) and interventions that address underlying causes like low stomach acid or slow motility would logically work in the same direction, though the clinical trial data on those approaches is thinner.
Indole Metabolites and the Brain
The indole pathway isn’t all bad news. Indole and several of its derivatives activate a receptor called the aryl hydrocarbon receptor, and this receptor turns out to be an important communication channel between the gut microbiome and the central nervous system. Tryptophan metabolites that signal through this receptor constitute a key interface of what researchers call the microbiome-gut-brain axis, connecting the gut to the brain via immune, metabolic, and neural pathways.14PubMed Central. Host-microbiome interactions: the aryl hydrocarbon receptor as a critical node in tryptophan metabolites to brain signaling Some of these microbially-derived compounds can cross the blood-brain barrier and influence brain function directly.15PubMed Central. The aryl hydrocarbon receptor as a mediator of host-microbiota interplay
In mouse experiments, indole itself promoted the growth of new neurons in the adult hippocampus, a process called neurogenesis. When researchers knocked out the aryl hydrocarbon receptor, this effect disappeared, confirming that the receptor is a necessary part of the signaling chain. The pathway activated by indole increased the expression of several genes associated with neural growth and development.16PubMed Central. Tryptophan-metabolizing gut microbes regulate adult neurogenesis via the aryl hydrocarbon receptor
This research is still in its early stages, and it would be premature to say that your indican level tells you anything specific about your brain health. But it adds an interesting layer to the picture: the very microbial process that produces indole (and downstream indican) also generates signaling molecules that the brain depends on. This is one reason why the relationship between gut bacteria and health is so hard to reduce to simple good-or-bad categories. The same metabolic pathway can produce both beneficial signaling compounds and potentially harmful waste products, depending on context, quantity, and how well the rest of the body handles the load.
Blue Diaper Syndrome and Rare Genetic Causes
Most cases of elevated indican stem from the digestive causes described above, but there is at least one rare genetic condition where indicanuria is a defining feature. Blue diaper syndrome is a familial disease involving a defect in the intestinal transport of tryptophan. Because the small intestine can’t absorb tryptophan properly, bacteria in the lower gut degrade the excess into large amounts of indole, which leads to dramatically elevated indican in the urine. When the indican in the diaper oxidizes to indigo blue upon exposure to air, it produces a striking bluish discoloration, which gives the condition its name.17The American Journal of Medicine. The blue diaper syndrome: Familial hypercalcemia with nephrocalcinosis and indicanuria
Blue diaper syndrome also involves hypercalcemia and nephrocalcinosis (calcium deposits in the kidneys), and the indicanuria is part of the diagnostic picture rather than an incidental finding. The condition is extremely rare, but it illustrates an important principle: the same metabolic pathway that produces modest amounts of urinary indican in healthy people can, under certain genetic circumstances, generate enough to visibly stain fabric blue.
Indican in Veterinary Medicine
Humans aren’t the only species where indican levels carry diagnostic weight. In horses, elevated blood and urine indican has been studied as a potential marker for equine grass sickness, a devastating condition that affects the nervous system controlling gut motility. Research at the University of Edinburgh found significantly higher indican concentrations in horses with acute equine grass sickness compared to control animals. The logic mirrors the human scenario: when the equine intestine is obstructed and bacterial putrefaction increases, circulating indican levels rise.18University of Edinburgh. Equine Grass Sickness Indican Study
Equine grass sickness is notoriously difficult to diagnose quickly, and a simple indican measurement could potentially speed up identification. This veterinary application reinforces how consistent the biology is across mammals: the tryptophan-to-indole-to-indican pathway works the same way, and disruptions to gut motility or bacterial balance show up in the same downstream metabolite regardless of the species involved.
Where the Science Stands
Indican occupies an awkward spot in clinical medicine. The biochemistry behind it is well understood and has been documented for well over a century. The connection between gut bacterial activity and urinary indican excretion is robust. And the downstream compound, indoxyl sulfate, is now recognized as a genuine driver of kidney and cardiovascular disease, not just a bystander. Yet the urinary indican test itself remains something of a niche tool, embraced more by functional medicine practitioners than by mainstream gastroenterologists or nephrologists.
Part of the reason is that the test result is nonspecific. A high indican level tells you that bacterial protein fermentation is elevated, but it doesn’t tell you where in the gut the problem is, which bacteria are responsible, or what the root cause might be. Modern diagnostic tools, including breath tests for bacterial overgrowth, stool analyses for microbial composition, and direct endoscopic evaluation, can often provide that information more directly. The old indican test, born in an era when a blue dye reaction was state-of-the-art chemistry, is now competing with far more granular approaches to the same clinical question. Whether it deserves a larger role in routine screening or remains a complementary marker is a question the field hasn’t definitively settled.